Streamlining Patient Access. The project was a collaboration with ICCE, OPI, NIR Ultrasound...
-
Upload
morgan-bates -
Category
Documents
-
view
217 -
download
2
Transcript of Streamlining Patient Access. The project was a collaboration with ICCE, OPI, NIR Ultrasound...
NEURO-INTERVENTIONAL ULTRASOUND
IBI OPUIYO,RDMS EXECUTIVE SPONSOR - JOSEPH STEELE,MD
Streamlining Patient Access
The project was a collaboration with ICCE, OPI, NIR Ultrasound technologists, nurses and faculty
Neuro-Interventional Ultrasound
Provide ultrasounds of the thyroid and neck regions
Referrals from various clinics throughout the institution including Endocrine, Melanoma, Head and Neck Surgery, and Lymphoma services
Number of completed patient exams in NIR US has grown in 5 year period
from just over 4,000 in FY06 to 10,000 exams and biopsies in FY11
PROBLEM
Who Is Impacted ?
Thoracic
PATIENTS
Melanoma
Head and Neck
SurgeryEndocrine
NIR
Other Referring Services
NIR US Project Goal
Decrease Delays
Increase Access
AIM
NIR will decrease the
number of days for referring
clinics to obtain diagnostic
scans for patients from 25 or
more working days to less
than 5 days by June 2011.
CAUSE ANALYSISIDENTIFYING & ASSESSING
Scheduling Environment Procedures
Limited slots for clinics
Patients
Floor Plan Issue: Waiting area, holding area, and US rooms are
far apart
Certain US rooms are only used for scanning
CLINIC HOURS OF OPERATION 8-4PM
Dictation between patients
Conferences and meetings
Adding patients without verifying current schedule
Check in early and want to be seen early
.
Lost in the hospital
Limited Patient Access to NIR
Diagnostic Scans and
Procedures
Nursing documentation take time
Wait for BX result and DIA to set up
Double duties
Allotted exam times:SCANS: 1HOURBX: 2 HOURS
No show
Multiple BXs @ once
Wait for requesting MD to reply
Arrive late (weather, traffic and other appts
Anxiety induce HTN
6 SCAN ROOMS,TECHSCongestion of appts.
PATIENT SCHEDULING TEMPLATE
WORKFLOW
PERSONNEL
CAUSE ANALYSIS
KEY ISSUES SCHEDULING
LIMITATIONS
OPERATIONS
PROCESSES
WORKFLOW
BASELINE DATAPERFORMANCE ASSESSED
Capacity Backlog : Scheduling
Max 38 potential appointment slots/day
25 day delay for next available appointment
Process Analysis: Scheduling
Issue: limited appointment slots
available
Operations: Processes
Workflow
Personnel
Situational Processes
Practical Processes
Operations: Asset Utilization
HIGH VOLUME
DATES NUMBER OF PROCEDURES
1/21/20111/24/20111/27/20111/31/2011
2/7/20112/9/2011
2/11/20112/15/20112/25/20112/28/2011
3/2/20113/4/20113/8/20113/9/2011
3/16/20113/23/20113/28/20113/29/20113/30/2011
4/1/20114/5/2011
57.6775.3765.7166.58
68.7266.643.760.9271.43
PRE TEMPLATE ROOM UTILIZATION
BEGIN TO LEAVE DEPT.
75.4155.37
4944
74.9649.0264.8157.4956.1745.864662.5958.9152.69
445244
4648
504647484949454754
47.57 61.19
5349
AVERAGE TIME IN MINUTES
4445 55.11
01020304050607080
40
56
4
40
56
7
40
57
0
40
57
4
40
58
1
40
58
3
40
58
5
40
58
9
40
59
9
40
60
2
40
60
4
40
60
6
40
61
0
40
61
1
40
61
8
40
62
5
40
63
0
40
63
1
40
63
2
40
63
4
40
63
8Av
era
ge
tim
e i
n R
oo
ms
High Volume Dates
Pre Template Room utilization
INTERVENTIONSPHASED APPROACH
SCHEDULE
Management team began complete restructuring of scheduling template
Opening of initial set of additional scheduling slots for servicing clinics. This addressed immediate bottleneck issues.
OPERATIONS
Personnel changes to accommodate expanded schedule.
1. New technologist schedule
2. New temporary Imaging Assistant
• Phase I• Feb 1, 2011 to March 10, 2011
SCHEDULE
Process changed for ordering diagnostic scans/biopsies
Communications and education of referring service Clinical Coordinators on forthcoming schedule template usage
OPERATIONS
Departmental operational hours expanded
• Phase II• March 11, 2011 to April 14, 2011
Go Live: opening of restructured scheduling template
Data gathered for 90 day assessment of combined changes
• Phase III• April 15,2011 to July 15, 2011
The success of the project was measured using two metrics
The number of available daily slots for procedures or scans.
The time to next appointment for a diagnostic ultrasound and biopsy
Results
The data reveals that measured improvements are attributed to :
SCHEDULE
The new scheduling template
NIR Clinical Operations Report Summary
Template Timeslots Available Jan. Feb. March April May June July
Scan w/biopsy timeslots 10 10 10 14 16 16 16
Scan only timeslots 18 18 23 24 25 25 25
Overbook timeslots 10 10 10 12 14 14 14
Total Timeslots 38 38 43 50 55 55 55
Available appointment slots increased from 38 to 55
Scheduling Template
Results
1/13
/201
1
1/18
/201
1
1/21
/201
1
1/25
/201
1
1/27
/201
1
2/4/
2011
2/18
/201
1
3/4/
2011
3/18
/201
1
4/1/
2011
4/15
/201
1
4/29
/201
1
5/13
/201
1
5/27
/201
1
6/10
/201
1
6/24
/201
1
7/8/
2011
0
10
20
30
40
50
60
70
80
NUMBER OF WORKDAYS FOR NEXT AVAILABLE APPOINTMENT
Scan/Biopsy Overbook
Scan/Biopsy Template
Scan Only Overbook
Scan Only Template
WORK WEEK
# W
OR
KD
AY
S
The data reveals that measured improvements are attributed to :
OPERATIONS
Pre assessments
Extended department hours of operation
Change in personnel (tech/MD) schedules
Additional Imaging Assistant (personnel changes)
New lead technologist role
AVERAGE TIME IN MINUTES:
Pre Template Post Template
61.19 minutes 54.63 minutes
Room utilization improved. The time to perform one complete procedure (time from patient entering the room to exiting the room) decreased 6.6 minutes.
0
10
20
30
40
50
60
70
80
90 Day NIR Room Utilization Times
Pre Template Room Uti-lization Times Jan 2011- Apr 2011Post Template Room Uti-lization Times Apr 2011- July 2011
90 Day Period
Ro
om
Usa
ge
Per
Pat
ien
t S
een
in
Min
ute
s
Calculation Summary / ROI
Year 0 Year 1 Year 2 Year 3
Cost of Capital 9.20%
Investments/Costs (3,906) 0 0 0
Benefit/Revenue 120,919 120,919 120,919
Annual Net Benefit/Revenue(Costs) (3,906) 120,919 120,919 120,919
Benefit/Revenue Including Soft Savings 120,919 120,919 120,919Annual Net Benefit (Costs) Including soft Savings (3,906) 120,919 120,919 120,919
Risk Adjusted ROI = Net Present Value of Cumulative Net Benefit / Net Present Value of Total CostsRA ROI(Margin for yrs 1-3 discounted @ Cost of Capital %) 6959%Net Present Value $275,722.78Internal Rate of Return (Expected Return) 3096%
NEXT STEPS
Thank You
NIR US Process Improvement Teams NIR US Manager Tonya Brightmon Executive Sponsor Dr. Steele